Proviti

Proviti is a Bulgarian company founded in 2011, specializing in biotechnological research and innovation within the nutrition and nutraceuticals sector. The company's core mission is to develop and commercialize scientific concepts, facilitating their transfer into marketable products.

A significant milestone for the company was the development and patent application for a new formula for an innovative probiotic product. This formula features their proprietary strain, L. Acidophilus Proviti, which has demonstrated probiotic qualities and the ability to absorb serum cholesterol in in-vitro tests. In 2013, Proviti launched its first product line under the brand VEDA Bulgarica, which includes a yogurt, yogurt drink, and capsules based on this proprietary strain.

The company's business model revolves around research and development, intellectual property generation, prototyping, and subsequent licensing or marketing of its product concepts. Proviti has actively built strategic partnerships to foster an innovation ecosystem, collaborating with entities like Sofia Tech Park, the Faculty of Chemistry and Pharmacy of Sofia University, and the Institute of Cryobiology and Food Technology. The company has also secured financing through the EU's Operational Programme “Competitiveness” and received investment from Innovation Capital (Bulgaria) to support its growth and the commercialization of its products.

Keywords: biotechnology, nutraceuticals, probiotics, research and development, nutrition science, Lactobacillus acidophilus, food technology, intellectual property, technology transfer, VEDA Bulgarica, synbiotics, microbial strain, digestive health, cholesterol absorption, innovation ecosystem